Deprescribing: Moving beyond barriers and facilitators

Wade Thompson*, Emily Reeve

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


Unnecessary polypharmacy continues to be a problem among older adults. The field of deprescribing (planned, supervised process of medication discontinuation) aims to address this problem. Deprescribing is a relatively new field despite having grown substantially in recent years. Much of the early research in this area focused on identifying barriers to and facilitators of deprescribing in clinical practice, which contributed to a large body of work on this topic. However, with continuing research around barriers and facilitators, we need to be mindful to undertake research that builds on existing knowledge, addresses known gaps, and advances the field. Additionally, there is a need in deprescribing research to shift focus to developing ways to address known barriers and harness knowledge of facilitators. That is, translating existing knowledge into strategies and tools that can impact clinical practice and lead to practical and sustained deprescribing efforts.

TidsskriftResearch in Social and Administrative Pharmacy
StatusAccepteret/In press - 2021

Bibliografisk note

Funding Information:
ER is supported by an Australian National Health and Medical Research Council (NHMRC) Dementia Research Development Fellowship.

Publisher Copyright:
© 2021 Elsevier Inc.


Dyk ned i forskningsemnerne om 'Deprescribing: Moving beyond barriers and facilitators'. Sammen danner de et unikt fingeraftryk.